Successful renal transplantation in primary hyperoxaluria

Area of Science:

• Nephrology
• Genetics
• Transplantation

Background:

• Primary hyperoxaluria is a rare genetic disorder leading to excessive oxalate production and kidney damage.
• Kidney transplantation is a potential treatment for end-stage renal disease caused by primary hyperoxaluria.
• Live related renal transplantation presents unique challenges and considerations in patients with primary hyperoxaluria.

Observation:

• A 29-year-old male with Type 1 primary hyperoxaluria underwent a successful live related renal transplant.
• Pre-transplant plasma oxalate levels were significantly elevated (160 µmol/L), with a large exchangeable oxalate pool (4429 µmol).
• Post-transplant, oxalate levels reduced but remained elevated, managed effectively with pyridoxine and dietary modifications.

Findings:

• The patient remained well 32 months post-transplant, with reduced but elevated oxalate levels.
• Pyridoxine therapy and avoidance of oxalate-rich foods were crucial in maintaining reduced oxalate levels.
• 24-hour urinary oxalate excretion was maintained near normal levels with the therapeutic regimen.

Implications:

• Live related renal transplantation can be a viable option for primary hyperoxaluria patients.
• Strict adherence to guidelines, including pyridoxine response, pre- and post-operative dialysis, and dietary management, is essential for success.
• These findings suggest that with appropriate management, renal transplantation offers a positive long-term outcome for primary hyperoxaluria.